ArticleBlood2017
Adaptive NK cells can persist in patients with
Open access · bronzeAbstract read
In one paragraph
Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.
0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 70 citations in OpenAlex.
- Adaptive Features of Natural Killer Cells in Multiple Sclerosis.Frontiers in immunology · 2019Trial
- Rewiring tumor immunity via zinc finger proteins: a new frontier in cancer immunotherapy.Journal of translational medicine · 2025Review
- NKG2C Sequence Polymorphism Modulates the Expansion of Adaptive NK Cells in Response to Human CMV.HLA · 2024Article
- Current Insights into CAR T-Cell-Based Therapies for Myelodysplastic Syndrome.Pharmaceutical research · 2024Review
- Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.Blood · 2024Article
- Process engineering of natural killer cell-based immunotherapy.Trends in biotechnology · 2023Review
- Unwinding the Role of the CMG Helicase in Inborn Errors of Immunity.Journal of clinical immunology · 2023Article
- The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies.Cancers · 2023Review
- Human natural killer cells: Form, function, and development.The Journal of allergy and clinical immunology · 2023Review
- Natural Killer Cell-Based Immunotherapy against Glioblastoma.International journal of molecular sciences · 2023Review
- Natural killer cells- from innate cells to the discovery of adaptability.Frontiers in immunology · 2023Review
- Clonal expansion and epigenetic inheritance of long-lasting NK cell memory.Nature immunology · 2022Article
- CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation.Transplantation and cellular therapy · 2022Article
- Natural killer cells in antiviral immunity.Nature reviews. Immunology · 2022Review
- A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies.Frontiers in immunology · 2022Review
- Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells.Frontiers in immunology · 2022Review
- Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges.Frontiers in immunology · 2022Review
- CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire.Frontiers in immunology · 2022Article
- Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.Cell stem cell · 2021Article
- Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.Cancers · 2021Review
Corrections and comments
- Commented on by
Authors and funding
21 authors at 8 institutions in 4 countries.
Heinrich SchlumsCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Moonjung JungHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Hongya HanCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Jakob TheorellCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Venetia BigleyInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Samuel C C ChiangCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
David S J AllanHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Jan K Davidson-MoncadaHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Rachel E DickinsonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Tim D HolmesCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Amy P HsuLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Danielle TownsleyHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Thomas WinklerHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Weixin WangDepartment of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD; and.
Pål AukrustSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
Ingvild NordøySection of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
Katherine R CalvoDepartment of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD; and.
Steve M HollandLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Matthew CollinInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Cynthia E DunbarHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Yenan T BrycesonCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Karolinska University Hospital · SENational Heart Lung and Blood Institute · USNational Institutes of Health · USNewcastle University · GBNational Institutes of Health Clinical Center · USOslo University Hospital · NOKarolinska Institutet · SEUniversity of Bergen · NO
Funding
Understanding hematopoietic stem cell mobilization and engraftmentZIAHL006063 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2010 to 2025
$23.5MThe rhesus macaque as a preclinical model for induced pluripotent stem cellsZIAHL006062 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2010 to 2024
$8.2MThe Role of microRNA in Hematologic MalignanciesZIACL090025 · CLC · CLINICAL CENTER · PI CALVO, KATHERINE · 2010 to 2025
$0kAbstract
Heterozygous
Indexed as
Cell ProliferationGATA2 Transcription FactorMutationAdolescentAdultCalmodulin-Binding ProteinsChildFemaleHematopoietic Stem CellsHumansInterleukin-12Interleukin-18Killer Cells, NaturalMaleMiddle AgedReceptors, IgECalmodulin-Binding ProteinsEWSR1 protein, humanFcepsilonRI gamma-chain, humanGATA2 protein, humanGATA2 Transcription FactorInterleukin-12Interleukin-18Receptors, IgERNA-Binding Protein EWSRNA-Binding ProteinsSH2D1B protein, humanSyk KinaseSYK protein, humanTranscription Factors
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.